PT1922309E - Derivados de n-fenil-2-pirimidina-amina e processo para a sua preparação - Google Patents

Derivados de n-fenil-2-pirimidina-amina e processo para a sua preparação Download PDF

Info

Publication number
PT1922309E
PT1922309E PT58088147T PT05808814T PT1922309E PT 1922309 E PT1922309 E PT 1922309E PT 58088147 T PT58088147 T PT 58088147T PT 05808814 T PT05808814 T PT 05808814T PT 1922309 E PT1922309 E PT 1922309E
Authority
PT
Portugal
Prior art keywords
pyrimidine
phenyl
preparation
amine derivatives
amine
Prior art date
Application number
PT58088147T
Other languages
English (en)
Inventor
Dong-Yeon Kim
Dae-Jin Cho
Gong-Yeal Lee
Hong-Youb Kim
Sun-Ahe Lee
Byoung-Cheol Han
Original Assignee
Il Yang Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Il Yang Pharm Co Ltd filed Critical Il Yang Pharm Co Ltd
Publication of PT1922309E publication Critical patent/PT1922309E/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Pyridine Compounds (AREA)
PT58088147T 2005-08-05 2005-09-07 Derivados de n-fenil-2-pirimidina-amina e processo para a sua preparação PT1922309E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020050071656A KR100674813B1 (ko) 2005-08-05 2005-08-05 N-페닐-2-피리미딘-아민 유도체 및 그의 제조방법

Publications (1)

Publication Number Publication Date
PT1922309E true PT1922309E (pt) 2014-09-02

Family

ID=37727490

Family Applications (1)

Application Number Title Priority Date Filing Date
PT58088147T PT1922309E (pt) 2005-08-05 2005-09-07 Derivados de n-fenil-2-pirimidina-amina e processo para a sua preparação

Country Status (16)

Country Link
US (1) US7501424B2 (pt)
EP (1) EP1922309B1 (pt)
JP (1) JP5094721B2 (pt)
KR (1) KR100674813B1 (pt)
CN (1) CN101155786B (pt)
AU (1) AU2005335298C1 (pt)
CA (1) CA2617991C (pt)
DK (1) DK1922309T3 (pt)
EA (1) EA015103B1 (pt)
ES (1) ES2493627T3 (pt)
MX (1) MX2008001221A (pt)
NZ (1) NZ564908A (pt)
PL (1) PL1922309T3 (pt)
PT (1) PT1922309E (pt)
RS (1) RS53379B (pt)
WO (1) WO2007018325A1 (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100654039B1 (ko) 2005-11-14 2006-12-05 에스케이 텔레콤주식회사 무선 인터넷에서 서비스 서버의 인증방법 및 이를 이용한결제방법
EP2222647B1 (en) 2006-10-23 2015-08-05 Cephalon, Inc. Fused bicyclic derivatives of 2,4-diaminopyrimidine as alk and c-met inhibitors
KR20090075889A (ko) * 2006-11-03 2009-07-09 아이알엠 엘엘씨 단백질 키나제 억제제로서의 화합물 및 조성물
BRPI0811516A2 (pt) * 2007-05-04 2014-11-18 Irm Llc Compostos e composições como inibidores de c-kit e pdgfr cinase
MX2009011950A (es) * 2007-05-04 2009-12-11 Irm Llc Derivados de pirimidina y composiciones como inhibidores de cinasa c-kit y pdgfr.
CA2689989A1 (en) 2007-06-04 2008-12-11 Avila Therapeutics, Inc. Heterocyclic compounds and uses thereof
ES2368876T3 (es) 2007-08-22 2011-11-23 Irm Llc Derivados de 2-heteroarilaminopirimidina como inhibidores de cinasa.
US20100016590A1 (en) * 2008-07-17 2010-01-21 Teva Pharmaceutical Industries Ltd. Nilotinib intermediates and preparation thereof
KR20100021321A (ko) * 2008-08-14 2010-02-24 일양약품주식회사 Ν-페닐-2-피리미딘-아민 유도체의 제조방법
CN102203084B (zh) 2008-11-05 2014-10-29 特瓦制药工业有限公司 盐酸尼洛替尼晶型
WO2010060074A1 (en) * 2008-11-24 2010-05-27 Teva Pharmaceutical Industries Ltd. Preparation of nilotinib and intermediates thereof
KR20130031296A (ko) 2010-05-21 2013-03-28 케밀리아 에이비 신규한 피리미딘 유도체
DK2688883T3 (en) 2011-03-24 2016-09-05 Noviga Res Ab pyrimidine
KR101369584B1 (ko) 2011-04-19 2014-03-06 일양약품주식회사 페닐-이속사졸 유도체 및 그의 제조방법
RU2486180C1 (ru) * 2011-11-02 2013-06-27 Общество с ограниченной ответственностью "ТехноХим" (ООО "ТехноХим") Способ получения 2-ариламино-4-гетарилпиримидинов
KR101956586B1 (ko) * 2012-03-27 2019-03-11 일양약품주식회사 약제학적 조성물 및 이의 제조방법
JP5910311B2 (ja) * 2012-05-23 2016-04-27 ニプロ株式会社 医薬錠剤およびその製造方法
CN104940748A (zh) * 2015-06-09 2015-09-30 林正兴 一种治疗胃癌的药物组合物
US11091466B2 (en) 2017-03-17 2021-08-17 Cardio Therapeutics Pty Ltd Heterocyclic inhibitors of PCSK9
CN107056713A (zh) * 2017-05-18 2017-08-18 厦门大学 4‑((4‑取代芳基‑2‑嘧啶基)氨基)苯甲酰肼衍生物及其制备方法和应用
CN111039932B (zh) * 2019-12-13 2023-09-12 安徽峆一药业股份有限公司 一种拉多替尼的高收率合成方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CO4940418A1 (es) 1997-07-18 2000-07-24 Novartis Ag Modificacion de cristal de un derivado de n-fenil-2- pirimidinamina, procesos para su fabricacion y su uso
WO2000069283A1 (en) * 1999-05-13 2000-11-23 The Nutrasweet Company USE OF ADDITIVES TO MODIFY THE TASTE CHARACTERISTICS OF N-NEOHEXYL-α-ASPARTYL-L-PHENYLALANINE METHYL ESTER
KR20020037065A (ko) * 1999-10-04 2002-05-17 에가시라 구니오 감미질이 개선된 고감미도 감미료 조성물, 미각 교정제 및이들의 용도
GB0021726D0 (en) * 2000-09-05 2000-10-18 Astrazeneca Ab Chemical compounds
GB0022438D0 (en) * 2000-09-13 2000-11-01 Novartis Ag Organic Compounds
WO2002024681A2 (en) 2000-09-20 2002-03-28 Ortho-Mcneil Pharmaceutical, Inc. Pyrazine derivatives as modulators of tyrosine kinases
US7129242B2 (en) * 2000-12-06 2006-10-31 Signal Pharmaceuticals, Llc Anilinopyrimidine derivatives as JNK pathway inhibitors and compositions and methods related thereto
JP4523271B2 (ja) * 2001-06-01 2010-08-11 バーテックス ファーマシューティカルズ インコーポレイテッド プロテインキナーゼのインヒビターとして有用なチアゾール化合物
US6958340B2 (en) * 2001-08-01 2005-10-25 Merck & Co., Inc. Tyrosine kinase inhibitors
ATE447560T1 (de) * 2002-06-28 2009-11-15 Nippon Shinyaku Co Ltd Amidderivat
GB0215676D0 (en) * 2002-07-05 2002-08-14 Novartis Ag Organic compounds
AU2004225965A1 (en) * 2003-03-25 2004-10-14 Vertex Pharmaceuticals Incorporated Thiazoles useful as inhibitors of protein kinases
EP1605946B1 (en) * 2003-03-25 2008-05-28 Vertex Pharmaceuticals Incorporated Thiazoles useful as inhibitors of protein kinases
AU2003232650A1 (en) 2003-05-06 2004-11-26 Il Yang Pharm Co., Ltd. N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
MXPA05013349A (es) * 2003-06-13 2006-03-09 Novartis Ag Derivados de 2-amino-pirimidina como inhibidores de quinasa raf.
WO2005063720A1 (ja) * 2003-12-25 2005-07-14 Nippon Shinyaku Co., Ltd. アミド誘導体及び医薬
CA2551529C (en) * 2003-12-25 2011-02-01 Nippon Shinyaku Co., Ltd. Amide derivative and medicine
JPWO2005113550A1 (ja) * 2004-05-20 2008-03-27 三菱ウェルファーマ株式会社 アミノピリミジン誘導体及びその医薬としての用途

Also Published As

Publication number Publication date
ES2493627T3 (es) 2014-09-12
JP5094721B2 (ja) 2012-12-12
EA015103B1 (ru) 2011-06-30
US7501424B2 (en) 2009-03-10
MX2008001221A (es) 2009-02-24
DK1922309T3 (da) 2014-08-25
RS20080002A (en) 2009-07-15
EP1922309B1 (en) 2014-05-21
WO2007018325A1 (en) 2007-02-15
CN101155786B (zh) 2012-08-29
AU2005335298A1 (en) 2007-02-15
CN101155786A (zh) 2008-04-02
AU2005335298B2 (en) 2010-05-27
PL1922309T3 (pl) 2014-11-28
EA200800516A1 (ru) 2008-08-29
NZ564908A (en) 2011-02-25
JP2009503060A (ja) 2009-01-29
EP1922309A4 (en) 2009-10-14
CA2617991A1 (en) 2007-02-15
AU2005335298C1 (en) 2010-11-25
KR100674813B1 (ko) 2007-01-29
EP1922309A1 (en) 2008-05-21
RS53379B (en) 2014-10-31
US20080096899A1 (en) 2008-04-24
CA2617991C (en) 2011-08-09

Similar Documents

Publication Publication Date Title
PT1922309E (pt) Derivados de n-fenil-2-pirimidina-amina e processo para a sua preparação
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
IL190135A0 (en) Process for the preparation of pyrimidinedione derivatives
IL185353A0 (en) Azabicycloalkane derivatives , pharmaceutical compositions containing the same and methods for the preparation thereof
IL186127A (en) Subcutaneous preparations for the treatment of depression and methods for their preparation
EP1895853A4 (en) YOGHURT BEAUTY PRODUCTS AND METHOD OF PREPARING THEM
EP1951682A4 (en) NEW 2-AMINOPYRIMIDONE OR 2-AMINOPYRIDINONE DERIVATIVES AND THEIR USE
HUP0500920A2 (en) Oxadiazole derivatives, process for their preparation and their use
TWI315305B (en) Piperidin-4-yl-amide derivatives,pharmaceutical compositions comprising the same,process for preparing the same and the use thereof
EP1893625A4 (en) PROCESS FOR THE PREPARATION OF 9-DEAZAPURINE DERIVATIVES
EP1962635A4 (en) LOAD REDUCTION FOR SHOULDER AND USE THEREOF
EP1731139A4 (en) PHARMACEUTICAL PREPARATION OF THE S / O TYPE AND MANUFACTURING METHOD THEREFOR
EP1961753A4 (en) DERIVATIVES OF PIRAZOLOPYRIMIDINONE, THEIR PREPARATION AND USE
EP1841581A4 (en) COMPOSITE MATERIALS AND METHOD FOR THE PRODUCTION AND USE THEREOF
AU2003232650A1 (en) N-phenyl-2-pyrimidine-amine derivatives and process for the preparation thereof
EP1834624A4 (en) MEDICAL COMPOSITION AND MANUFACTURING METHOD THEREFOR
HK1102395A1 (en) Indene derivatives and process for the preparation thereof
EP1874722A4 (en) HYDROXAMIC ACID DERIVATIVES AND PROCESSES FOR PREPARING THE SAME
IL213474A0 (en) Processes for the preparation of cyclopropyl-amide derivatives
IL183702A0 (en) Difluoronucleosides and process for preparation thereof
EP1756036A4 (en) INDENED DERIVATIVES AND PROCESS FOR THEIR PREPARATION
HK1100946A1 (en) 1-a-HALO-2,2-DIFLUORO-2-DEOXY-D-RIBOFURANOSE DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
IL189698A0 (en) Thiomorpholine derivatives and processes for the preparation thereof
IL194737A0 (en) 2-alkenyl-3-aminothiophene derivatives and processes for the preparation thereof